Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials -- Ignore unavailable to you. Want to Upgrade?

To: wiz who wrote (72)	7/13/1999 12:03:00 AM
From: glen	Read Replies (1) \| Respond to of 250

As a short term trade, bailing @ 17 made sense since 17 1/2 certainly appeared as temporary resistance. No one could have foreseen that VXGN was going to run all the way up to 22 1/2 today and make a new, substantially higher daily close of 21. On the other hand, as a long term trade, VXGN is a keeper. Bear in mind, that the potential market for AIDSVAX is the entire world's population that is not infected with any HIV strains. We're talking a multi-billion dollar market for a vaccine that is 2 years ahead of it's closest competitor. Also remember that there is no known cure yet for HIV infected individuals. So I ask you, what is the value of a company that may take the world down the road that will lead to the beginning of the eradication of this most dreadful and deadly disease. Certainly, a lot more than the market is currently pricing it at. The market cap is limited, and the demand should only grow as the VXGN story is understood by more and more people. There is no other company on the market with a product like AIDSVAX, and that that is as advanced in its Phase III Human Clinical Trials. This is a pure play on the potentially first to market of an AIDS preventative vaccine. The future risk/reward is absolutely staggering to the upside and is certainly worth trading/and or holding for much more than just 1 point. Well, the conclusions are JMHO, but I do belive VXGN has the potential to see $100-200/share. I am not selling any of my shares, which is just that many fewer in the float. Regards, glen